12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Cadrenal Therapeutics (NASDAQ:CVKD) shares moved upwards by 8.5% to $1.15 during Monday’s after-market session. The market value…
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers NexImmune (NASDAQ:NEXI) shares rose 97.5% to $14.95 during Tuesday’s regular session. The company’s market cap stands at…
Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Omega Therapeutics (NASDAQ:OMGA) shares increased by 99.6% to $5.45 during Thursday’s regular session. The market value of…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Omega Therapeutics (NASDAQ:OMGA) shares rose 110.6% to $5.75 during Thursday’s pre-market session. The market value of their…
Adicet Bio Sets 2024 Goals: Advancing Allogeneic Gamma Delta T Cell Therapies in Oncology and Autoimmune
Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases, today provided corporate updates and
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Exicure (NASDAQ:XCUR) stock increased by 63.9% to $0.66 during Friday’s pre-market session. The market value of their…
Wedbush Maintains Outperform Rating for Adicet Bio: Here’s What You Need To Know
Wedbush has decided to maintain its Outperform rating of Adicet Bio (NASDAQ:ACET) and lower its price target from…